A look at Sangamo Therapeutics Inc’s (SGMO) recent performance gives investors their first glimpse of hope.

November 20, 2023, Sangamo Therapeutics Inc (NASDAQ: SGMO) trading session started at the price of $0.3855, that was 7.88% jump from the session before. During the day, the shares moved up to $0.451 and dropped to $0.382 before settling in for the closing price of $0.38. A 52-week range for SGMO has been $0.29 – $3.76.

Elon Musk just Triggered a BOOM in These Stocks

Something strange is happening in the stock market…. This select group of stocks are going absolutely bananas. And it's all because of Elon Musk. Get your copy of "Top 5 Tech Stocks to Buy in 2024"

Click Here to Download the FREE Report.


During the last 5-year period, the sales growth of Healthcare Sector giant was 32.37%. When this article was written, the company’s average yearly earnings per share was at -9.52%. With a float of $158.30 million, this company’s outstanding shares have now reached $166.79 million.

Let’s determine the extent of company efficiency that accounts for 478 employees. In terms of profitability, gross margin is +89.12, operating margin of -180.85, and the pretax margin is -172.37.

Sangamo Therapeutics Inc (SGMO) Insider Activity

Also, it is sometimes useful to examine the sentiment of large-scale investors toward Sangamo Therapeutics Inc stocks. The insider ownership of Sangamo Therapeutics Inc is 10.74%, while institutional ownership is 58.06%. The most recent insider transaction that took place on Sep 26, was worth 3,000,000. In this transaction 10% Owner of this company sold 6,000,000 shares at a rate of $0.50, taking the stock ownership to the 17,652,466 shares.

Sangamo Therapeutics Inc (SGMO) Earnings and Forecasts

Going through the last 3-months fiscal report unveiled on the 9/29/2023, it has been observed that the corporation posted -$0.59 earnings per share (EPS) during the time that was less than consensus figure (set at -$0.32) by -$0.27. This company achieved a net margin of -172.76 while generating a return on equity of -57.37. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.11 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around -9.52% per share during the next fiscal year.

Sangamo Therapeutics Inc (NASDAQ: SGMO) Trading Performance Indicators

You can see what Sangamo Therapeutics Inc (SGMO) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 3.04. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.37.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.44, a number that is poised to hit -0.26 in the next quarter and is forecasted to reach -0.51 in one year’s time.

Technical Analysis of Sangamo Therapeutics Inc (SGMO)

Looking closely at Sangamo Therapeutics Inc (NASDAQ: SGMO), its last 5-days average volume was 2.59 million, which is a jump from its year-to-date volume of 2.04 million. As of the previous 9 days, the stock’s Stochastic %D was 56.63%. Additionally, its Average True Range was 0.06.

During the past 100 days, Sangamo Therapeutics Inc’s (SGMO) raw stochastic average was set at 8.99%, which indicates a significant decrease from 33.59% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 154.25% in the past 14 days, which was higher than the 105.30% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $0.5721, while its 200-day Moving Average is $1.3357. However, in the short run, Sangamo Therapeutics Inc’s stock first resistance to watch stands at $0.4500. Second resistance stands at $0.4850. The third major resistance level sits at $0.5190. If the price goes on to break the first support level at $0.3810, it is likely to go to the next support level at $0.3470. Should the price break the second support level, the third support level stands at $0.3120.

Sangamo Therapeutics Inc (NASDAQ: SGMO) Key Stats

There are 177,347K outstanding shares of the company, which has a market capitalization of 73.60 million. As of now, sales total 111,300 K while income totals -192,280 K. Its latest quarter income was 9,400 K while its last quarter net income were -104,160 K.


On What Basis Did Swvl Holdings Corp (SWVL) Stock Rise 47% Pre-Hours?

When last checked, Swvl Holdings Corp. (Nasdaq: SWVL), a...

What Drove Organovo (ONVO) Stock Up 15% In After-Hour Session On Tuesday?

Shares of Organovo Holdings Inc. (Nasdaq: ONVO) were up...

Is There Any Reason As To Why The Zai Lab (ZLAB) Stock Expanded By 13%?

The biopharmaceutical business Zai Lab Limited (NASDAQ: ZLAB), which...



Don't miss

Wearable Devices (WLDS) Stock Rose 12% On Tuesday, But On What Basis?

Wearable Devices Ltd (NASD: WLDS) is experiencing significant growth...

Did Anything Boost ObsEva (OBSV) Stock In Pre-Hours Trading?

Following an update, shares of ObsEva SA (NASD: OBSV)...

How Did The Kalera (KAL) Stock Rise 32% Pre-Hours?

At the time of the most recent check, shares...

Why Has Selina Hospitality (SLNA) Stock Increased In Extended Session On Friday?

The stock of Selina Hospitality PLC (NASD: SLNA), which...

Rocket Pharmaceuticals Inc (RCKT) surge 12.73% in a week: will this be a lucky break through?

Rocket Pharmaceuticals Inc (NASDAQ: RCKT) started the day on December 07, 2023, with a price increase of 1.82% at $26.30. During the day, the...

California Resources Corporation (CRC) Open at price of $49.34: A Brand-New Opportunity for Investors

California Resources Corporation (NYSE: CRC) open the trading on December 07, 2023, with a bit cautious approach as it glided -0.14% to $49.12. During...

Wayfair Inc (W) Open at price of $52.35: A Brand-New Opportunity for Investors

Witnessing the stock’s movement on the chart, on December 07, 2023, Wayfair Inc (NYSE: W) remained unchanged to $53.07. During the day, the stock...


Please enter your comment!
Please enter your name here